Reinfection
Showing 1 - 25 of 404
COVID-19 Testing Trial in Aurora
Active, not recruiting
- COVID-19 Testing
-
Aurora, ColoradoKaiser Permanente
Nov 30, 2022
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
Recruiting
- COVID-19 Infection
- Immunization; Infection
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Mar 15, 2023
Characteristics of SARS-CoV-2 Reinfection
Enrolling by invitation
- COVID-19
-
Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Feb 24, 2023
Cmv Congenital, CMV Viremia Trial in São Paulo (Women Enrolled, Newborns of Female Study Participants)
Not yet recruiting
- Cmv Congenital
- CMV Viremia
- Women Enrolled
- Newborns of Female Study Participants
-
São Paulo, BrazilUniversity of Sao Paulo
Aug 17, 2022
Health Outcomes in Older Adults
Not yet recruiting
- Long COVID
- +5 more
- no interventions
-
Beijing, Beijing, ChinaPeking University
Apr 21, 2023
Knee Infection Trial in Otwock (stabilization with stem, stabilization with sleeve)
Recruiting
- Knee Infection
- stabilization with stem
- stabilization with sleeve
-
Otwock, Mazowieckie, PolandGruca Teaching Hospital, Centre of Postgraduate Medical Centre
Mar 14, 2022
Genetics of Hyperimmunoglobulin E Recurrent Infection Syndrome
Recruiting
- Infections
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Examining Hepatitis C Reinfection Rates in Kenya
Completed
- Hepatitis C
-
Nairobi, KenyaNASCOP
Apr 19, 2021
Hepatitis C Virus Infection, Response to Therapy of, Drug Use Trial in Belgium (Blood sampling, questionaires)
Recruiting
- Hepatitis C Virus Infection, Response to Therapy of
- Drug Use
- Blood sampling
- questionaires
-
Antwerp, Belgium
- +9 more
Aug 25, 2021
Dengue Trial in Syracuse (Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge
Not yet recruiting
- Dengue
- Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
- Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Jul 28, 2023
COVID-19 Infections and Re-infection
Recruiting
- Covid-19
- SARS-CoV Infection
-
Montpellier, FranceUh Montpellier
Jan 3, 2022
HCV Reinfection in HD Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 22, 2021
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 23, 2021
Hepatitis C Trial in Dundee (Volitional Help Sheet)
Completed
- Hepatitis C
- Volitional Help Sheet
-
Dundee, United KingdomCairn Centre Needle Exchange
Aug 12, 2020
Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States
Not yet recruiting
- Cystic Fibrosis Lung
- +2 more
- RSP-1502
- Tobramycin inhalation solution
-
Tucson, Arizona
- +14 more
Aug 24, 2023
Immunity, Neutralization of COVID-19 Virus and Reinfections in
Withdrawn
- SARS-COV-2
- Blood and Saliva collection
-
Montreuil, Ile De France, France
- +1 more
Jun 17, 2021
Community-Assoc. S. Aureus Colonization and Recurrent Infection
Completed
- MRSA
- Antibiotics Given
- Antibiotics not given
-
Springfield, IllinoisSIU School of Medicine
Jun 25, 2020
Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)
Completed
- Hepatitis C, Chronic
- Opioid-use Disorder
-
Pittsburgh, PennsylvaniaMagee Womens Hospital of UPMC
Aug 19, 2022
Helminthiasis, Ascaris Infection, Trichuris Infection Trial in Panyabungan (Health hygiene education)
Unknown status
- Helminthiasis
- +4 more
- Health hygiene education
-
Panyabungan, North Sumatera, IndonesiaSingkuang sub-district, Mandailing Natal district
Jan 10, 2020
Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or
Active, not recruiting
- Chronic Hepatitis C
- People Who Inject Drugs
- velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
-
Atlanta, GeorgiaWellstar Atlanta Medical Center
May 31, 2023
Gram-negative Bacteremia Trial (De-escalation VS No De-escalation, Oral beta-lactams VS non beta-lactams, Central vascular
Not yet recruiting
- Gram-negative Bacteremia
- De-escalation VS No De-escalation
- +4 more
- (no location specified)
May 30, 2023
Schistosomiasis, Schistosoma Mansoni Trial in Leiden (Schistosoma mansoni infection, Placebo mock infection)
Completed
- Schistosomiasis
- Schistosoma Mansoni
- Schistosoma mansoni infection
- Placebo mock infection
-
Leiden, NetherlandsLeiden University Medical Center
Jan 27, 2023
Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment
Recruiting
- Hepatitis C
- HIV Coinfection
- Low intensity HCV treatment adherence support
- +2 more
-
Chennai, Tamil Nadu, IndiaYR Gaitonde Centre for AIDS Research and Education
May 12, 2022